Difficulty: Intermediate | Prerequisites: Parts 1 and 2 (imaging techniques, cell compartments, membrane structure)
Each organelle has a distinct structure that matches its function: the nucleus stores DNA behind a double membrane, mitochondria fold their inner membrane into cristae to maximise ATP output, lysosomes maintain an acidic interior for digestion, and so on. When organelles malfunction, the result is disease: mitochondrial dysfunction impairs energy supply, lysosomal storage disorders block cellular cleanup, and cytoskeletal or protein-aggregation defects drive neurodegeneration.
Nuclear envelope
The double membrane surrounding the nucleus, perforated by nuclear pores that regulate traffic between the nucleus and cytoplasm. Think of it as a wall with controlled gates: large molecules like mRNA and ribosomal subunits need to pass through the pores to get in or out.
Cristae
The inward folds of the mitochondrial inner membrane that increase surface area for oxidative phosphorylation. In simple terms, these folds pack more ATP-producing machinery into a small space.
Cisternae
The flattened, membrane-bound sacs that make up the Golgi apparatus (and parts of the ER). Think of them as a stack of processing stations: proteins and lipids move through the stack and get modified at each level.
Catalase
An enzyme found in peroxisomes that breaks down hydrogen peroxide (H2O2) into water and oxygen. In simple terms, catalase neutralises a toxic by-product of metabolism before it can damage the cell.
Hydrolytic enzymes
Enzymes that break chemical bonds by adding water (hydrolysis). Found in high concentration in lysosomes. Think of them as the cell's digestive enzymes, working best in the acidic environment lysosomes maintain (around pH 5).
Autophagy
The process by which a cell digests its own damaged organelles or proteins, typically by enclosing them in a membrane and fusing the resulting vesicle with a lysosome. In simple terms, autophagy is the cell's self-cleaning programme.
Ubiquitin
A small protein tag attached to damaged or misfolded proteins, marking them for degradation by the proteasome. Think of it as a "destroy me" label: once a protein has enough ubiquitin tags, the proteasome recognises and breaks it down.
Phospholipid bilayer with embedded proteins
Acts as the cell's boundary, controlling entry and exit of substances
Facilitates cell communication (receptors) and adhesion (junction proteins)
Surrounded by a double-membrane nuclear envelope with nuclear pores
Contains chromatin (DNA wrapped around histone proteins) and the nucleolus
Controls gene expression, DNA replication, and RNA processing
Nuclear pores regulate transport of mRNA, ribosomal subunits, and regulatory proteins between nucleus and cytoplasm
Double-membrane structure: smooth outer membrane, highly folded inner membrane (cristae)
Cristae increase the surface area available for the electron transport chain and ATP synthase
Primary site of ATP production via oxidative phosphorylation
Also involved in apoptosis (programmed cell death), calcium signalling, and metabolic regulation
Have their own DNA (mtDNA) and ribosomes, evidence of endosymbiotic origin
Single-membrane-bound organelles
Contain oxidative enzymes, notably catalase and various oxidases
Break down very-long-chain fatty acids via beta-oxidation
Detoxify harmful substances, including hydrogen peroxide (H2O2), which catalase converts to water and oxygen
Single-membrane-bound, maintained at acidic pH (~5) by proton pumps
Contain roughly 50 different hydrolytic enzymes (acid hydrolases)
Degrade macromolecules, damaged organelles, and engulfed pathogens
Central to autophagy (digesting the cell's own components) and phagocytosis (digesting foreign material)
Sorting stations for material brought into the cell by endocytosis
Early endosomes: first receiving compartment for endocytosed cargo
Late endosomes: mature from early endosomes, become more acidic, fuse with lysosomes
Recycling endosomes: return receptors and membrane components to the plasma membrane
Transport endosomes: shuttle cargo between compartments within the cell
Continuous membrane network connected to the nuclear envelope
Rough ER: studded with ribosomes on the cytoplasmic face; synthesises membrane proteins and secretory proteins; performs initial protein folding and quality control
Smooth ER: lacks ribosomes; synthesises lipids, metabolises carbohydrates, detoxifies drugs and poisons, stores calcium ions
Stack of flattened cisternae with distinct cis (receiving) and trans (shipping) faces
Receives proteins and lipids from the ER via transport vesicles
Modifies them (glycosylation, phosphorylation, proteolytic cleavage), sorts them, and packages them into vesicles for their final destination
Produces lysosomes and secretory vesicles
Bud from the trans-Golgi network
Transport proteins and lipids to the plasma membrane for release by exocytosis
Responsible for secretion of hormones, neurotransmitters, and digestive enzymes
The aqueous fluid matrix filling the cell (distinct from cytoplasm, which includes organelles)
Contains dissolved ions, enzymes, metabolites, and signalling molecules
Site of many metabolic pathways, including glycolysis, the pentose phosphate pathway, and fatty acid synthesis
Dense, non-membrane-bound structure within the nucleus
Synthesises ribosomal RNA (rRNA) and assembles ribosomal subunits
Larger and more prominent in cells with high protein synthesis demands
Cylindrical structures composed of nine triplets of microtubules arranged in a ring
Found in pairs (together forming the centrosome) near the nucleus
Organise the mitotic spindle during cell division, ensuring accurate chromosome segregation
Also involved in forming cilia and flagella
A network of three types of protein filaments:
Microtubules: hollow tubes of tubulin; the thickest (25 nm diameter); provide tracks for intracellular transport (motor proteins kinesin and dynein), form the mitotic spindle, and give structural rigidity
Microfilaments (actin filaments): the thinnest (7 nm); involved in cell shape, muscle contraction, cytokinesis, and amoeboid movement
Intermediate filaments: mid-range diameter (~10 nm); provide mechanical strength and resist tension; examples include keratins (epithelial cells), vimentin (connective tissue), and neurofilaments (neurons)
Composed of ribosomal RNA (rRNA) and proteins, arranged in a large and a small subunit
Sites of protein synthesis (translation of mRNA into polypeptide chains)
Free ribosomes: in the cytosol, typically synthesise proteins used within the cell
Bound ribosomes: attached to rough ER, synthesise membrane proteins and proteins destined for secretion or lysosomes
Large barrel-shaped protein complexes
Degrade ubiquitin-tagged proteins by unfolding them and cleaving them into short peptides
Essential for protein quality control: remove misfolded, damaged, or no-longer-needed regulatory proteins
Proteasome dysfunction is linked to neurodegenerative diseases where protein aggregates accumulate
Organelle dysfunction sits at the root of a wide range of diseases. The source material highlights three broad categories.
Impaired ATP production starves energy-hungry tissues, particularly muscle and the nervous system
Mitochondrial diseases can be inherited through maternal mtDNA or nuclear DNA mutations affecting mitochondrial proteins
Clinical signs often include muscle weakness, exercise intolerance, neurological symptoms, and lactic acidosis
Caused by deficiency of one or more lysosomal hydrolytic enzymes
Without the enzyme, specific substrates accumulate inside lysosomes, disrupting cell function
Examples: Tay-Sachs disease (hexosaminidase A deficiency, GM2 ganglioside accumulates), Gaucher disease (glucocerebrosidase deficiency), Pompe disease (acid maltase deficiency)
Symptoms vary by the substrate that accumulates and the tissues affected
Defects in protein quality control (proteasome dysfunction, impaired autophagy) lead to accumulation of misfolded protein aggregates
Cytoskeletal abnormalities (e.g. neurofilament dysfunction) can impair axonal transport and contribute to motor neuron disease
Examples: Alzheimer disease (amyloid-beta and tau aggregates), Parkinson disease (alpha-synuclein aggregates), ALS (motor neuron degeneration with cytoskeletal involvement)
The source material's clinical case describes a patient with chronic upper motor neuron dysfunction and acute weakness, which could involve any combination of mitochondrial energy failure, lysosomal storage, or protein-aggregation pathology.
Lysosomal storage disorders are now treated with enzyme replacement therapy, where the missing hydrolase is manufactured and infused into the patient. This only works because cells have a receptor-mediated endocytosis pathway (mannose-6-phosphate receptor) that routes the replacement enzyme to lysosomes. Mitochondrial dysfunction is increasingly recognised as a contributor to common conditions beyond rare genetic diseases, including type 2 diabetes, heart failure, and age-related neurodegeneration.
Students often treat the Golgi as a simple "shipping department." It is also a modification centre: glycosylation, phosphorylation, and proteolytic processing all occur there. Exams test the modification function, not just the packaging.
The rough and smooth ER are sometimes treated as entirely separate organelles. They are continuous with each other and with the nuclear envelope.
Students frequently confuse lysosomes and proteasomes. Lysosomes are membrane-bound compartments that degrade large structures using acid hydrolases. Proteasomes are cytosolic barrel-shaped complexes that degrade individual ubiquitin-tagged proteins. Different machinery, different targets.
Mitochondria are sometimes described as if they only produce ATP. They also regulate apoptosis, calcium homeostasis, and aspects of lipid metabolism.
Know the structural details that distinguish each organelle: double vs single membrane, presence of ribosomes, cristae vs cisternae. Exams frequently give you a description and ask you to identify the organelle.
The endomembrane system pathway (ER to Golgi to plasma membrane/lysosome) is a favourite for ordering questions: "place the following steps in the correct sequence."
Be able to connect a clinical scenario to the organelle involved: muscle weakness and lactic acidosis points to mitochondria; substrate accumulation in lysosomes points to a storage disorder; protein aggregates point to proteasome or autophagy failure.
Understand ubiquitin tagging and the proteasome pathway. This is tested both in cell biology and in pathology courses.
True or false: The Golgi apparatus receives material from the ER at its trans face.
False. The Golgi receives material at its cis face and ships it from the trans face.
Fill in the blank: Damaged or misfolded proteins are tagged with ______ before being degraded by the proteasome.
Ubiquitin.
True or false: Smooth ER is the primary site of protein synthesis.
False. Rough ER handles protein synthesis. Smooth ER is involved in lipid synthesis, detoxification, and calcium storage.
Fill in the blank: The inner membrane folds of mitochondria, which increase surface area for ATP production, are called ______.
Cristae.
True or false: Lysosomes maintain a neutral pH internally.
False. Lysosomes maintain an acidic pH of roughly 5, which is required for their hydrolytic enzymes to function.
Q: A patient has a genetic deficiency of a specific lysosomal enzyme. What category of disease is this, and what happens at the cellular level?
A: This is a lysosomal storage disorder. Without the enzyme, the substrate it normally degrades accumulates inside lysosomes, eventually impairing cell function and causing tissue damage. The specific symptoms depend on which enzyme is missing and which substrate builds up.
Q: Trace the path of a secretory protein from synthesis to release outside the cell, naming each compartment it passes through.
A: Ribosome on rough ER (synthesis and initial folding) to ER lumen to transport vesicle to cis-Golgi (modification and sorting through the Golgi stack) to trans-Golgi to secretory vesicle to plasma membrane (exocytosis).
Q: How do proteasomes and lysosomes differ in their roles in protein degradation?
A: Proteasomes are cytosolic barrel-shaped complexes that degrade individual ubiquitin-tagged proteins into short peptides. Lysosomes are membrane-bound acidic compartments that degrade larger structures (macromolecules, organelles, pathogens) using hydrolytic enzymes. Proteasomes handle targeted, single-protein quality control. Lysosomes handle bulk digestion and autophagy.
Q: Why are mitochondrial diseases often most severe in muscle and nerve tissue?
A: Muscle and nerve tissue have the highest energy demands in the body. When mitochondria cannot produce sufficient ATP, these tissues are the first and most severely affected.
Q: Name the three types of cytoskeletal filaments and give one function of each.
A: Microtubules (intracellular transport, mitotic spindle formation), microfilaments/actin filaments (cell shape, muscle contraction, cytokinesis), and intermediate filaments (mechanical strength and tension resistance).
The endomembrane system (ER, Golgi, vesicles, lysosomes, endosomes) is a natural extension of the membrane structure and transport material in Part 2. Understanding how proteins are synthesised on the rough ER, modified in the Golgi, and delivered to their destinations is foundational for signal transduction, immunology (antigen presentation), and pharmacology (drug targeting). The clinical correlations here connect forward to pathology and genetics courses, where lysosomal storage diseases and mitochondrial inheritance are standard exam content.
Plasma membrane, nuclear envelope, nuclear pore, chromatin, histones, mitochondria, cristae, oxidative phosphorylation, mtDNA, endosymbiotic theory, peroxisomes, catalase, oxidases, beta-oxidation, lysosomes, hydrolytic enzymes, acid hydrolases, autophagy, phagocytosis, endosomes, early endosomes, late endosomes, recycling endosomes, transport endosomes, rough ER, smooth ER, Golgi apparatus, cisternae, cis face, trans face, glycosylation, secretory vesicles, exocytosis, cytosol, glycolysis, nucleolus, rRNA, ribosomal subunits, centriole, centrosome, mitotic spindle, cytoskeleton, microtubules, microfilaments, actin, intermediate filaments, keratin, vimentin, neurofilaments, kinesin, dynein, ribosomes, proteasomes, ubiquitin, ubiquitin-proteasome pathway, protein quality control, lysosomal storage disorders, Tay-Sachs, Gaucher disease, Pompe disease, mitochondrial disease, neurodegeneration, Alzheimer, Parkinson, ALS, cell biology, University of Florida